Aethlon Medical

Aethlon Medical is a medical technology company based in San Diego, California, that specializes in developing immunotherapeutic products aimed at diagnosing and treating life-threatening diseases, including infectious diseases and cancer. The company's flagship product, the Aethlon Hemopurifier, is a clinical-stage device designed to selectively remove harmful exosomes and viruses from the human circulatory system. Additionally, Aethlon is advancing TauSome, an exosomal biomarker candidate intended for the diagnosis of chronic traumatic encephalopathy in living patients. The company collaborates with the University of Pittsburgh on research related to head and neck cancer, reflecting its commitment to addressing unmet medical needs in both health care and biodefense. Founded in 1999, Aethlon Medical continues to develop innovative technologies that target disease-causing particles in the bloodstream.